TABLE 3.
ORs of myocardial infarction per minor allele of rs11206510 (PCSK9) by LC n–3 PUFAs, EPA, DPA, DHA, and fish intakes1
Model 1 |
Model 2 |
||||
Type and tertile of intake | Mean ± SD2 | OR (95% CI) | P-interaction | OR (95% CI) | P-interaction |
LC n–3 PUFA, % of total energy intake | 0.027 | 0.012 | |||
First | 0.07 ± 0.02 | 1.05 (0.82, 1.35) | 0.97 (0.74, 1.27) | ||
Second | 0.12 ± 0.01 | 0.71 (0.56, 0.91) | 0.75 (0.58, 0.98) | ||
Third | 0.24 ± 0.12 | 0.71 (0.56, 0.91) | 0.66 (0.51, 0.86) | ||
EPA, % of total energy intake | 0.174 | 0.162 | |||
First | 0.02 ± 0.004 | 0.86 (0.67, 1.11) | 0.82 (0.62, 1.07) | ||
Second | 0.03 ± 0.004 | 0.95 (0.75, 1.21) | 0.97 (0.74, 1.25) | ||
Third | 0.07 ± 0.05 | 0.64 (0.50, 0.82) | 0.60 (0.46, 0.78) | ||
DPA, % of total energy intake | 0.099 | 0.129 | |||
First | 0.01 ± 0.004 | 0.93 (0.71, 1.20) | 0.88 (0.67, 1.16) | ||
Second | 0.03 ± 0.003 | 0.86 (0.67, 1.11) | 0.90 (0.68, 1.19) | ||
Third | 0.04 ± 0.01 | 0.69 (0.54, 0.86) | 0.65 (0.51, 0.84) | ||
DHA, % of total energy intake | 0.013 | 0.003 | |||
First | 0.03 ± 0.01 | 0.91 (0.71, 1.15) | 0.87 (0.67, 1.13) | ||
Second | 0.06 ± 0.01 | 0.85 (0.66, 1.09) | 0.87 (0.67, 1.13) | ||
Third | 0.14 ± 0.08 | 0.68 (0.53, 0.88) | 0.61 (0.47, 0.81) |
Model 1 (n = 3987) was adjusted for matching variables (age, sex, and area of residence). Model 2 (n = 3813) was adjusted as for model 1 and for waist-to-hip ratio, alcohol consumption, current smoking status, aspirin use, physical activity, family history of myocardial infarction, history of diabetes, history of hypertension, history of hypercholesterolemia, and genetic admixture. DPA, docosapentaenoic acid; LC, long chain; PCSK9, proprotein convertase subtilisin/kexin type 9.
For continuous variables.